This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Schwartz, M. D. Articles by Lerman, C. Search for Related Content PubMed PubMed Citation Articles by Schwartz, M. D. Articles by Lerman, C.

Spiritual Faith and Genetic Testing Decisions among High-Risk Breast Cancer Probands¹

Lombardi Cancer Center, Georgetown University Medical Center, Washington, D.C. 20007

Despite widespread access to genetic testing for the BRCA1 and BRCA2 breast cancer susceptibility genes, little is known about rates or predictors of test use among individuals from newly ascertained high-risk families who have self-referred for genetic counseling/testing. The objective of this study was to examine rates of test use within this population. In addition, we sought to determine whether spiritual faith and psychological factors influenced testing decisions. Participants were 290 women with familial breast cancer. All were offered genetic counseling and testing for alterations in the BRCA1 and BRCA2 genes. Baseline levels of spiritual faith, cancer-specific distress, perceived risk, and demographic factors were examined to identify independent predictors of whether participants received versus declined testing. The final logistic model revealed statistically significant main effects for spiritual faith [odds ratio (OR), 0.2; 95% confidence intervals (CIs), 0.1 and 0.5] and perceived ovarian cancer risk (OR, 2.4; 95% CIs, 1.3 and 4.7) and a statistically significant spiritual faith by perceived risk interaction effect. Among women who perceived themselves to be at low risk of developing breast cancer again, those with higher levels of spiritual faith were significantly less likely to be tested, compared with those with lower levels of faith (OR, 0.2; 95% CIs, 0.1 and 0.5). However, among women with high levels of perceived risk, rates of test use were high, regardless of levels of spiritual faith (OR, 1.2; 95% CIs, 0.4 and 3.0). These results highlight the role that spirituality may play in the decision-making process about genetic testing.

This article has been cited by other articles:

				K. Brewster, E. P. Wileyto, L. Kessler, A. Collier, B. Weathers, J. E. Stopfer, S. Domchek, and C. H. Halbert Sociocultural Predictors of Breast Cancer Risk Perceptions in African American Breast Cancer Survivors Cancer Epidemiol. Biomarkers Prev., February 1, 2007; 16(2): 244 - 248. [Abstract] [Full Text] [PDF]

				J. E. Rohrer, S. H. Lim, and F. A. Bock Medical Condition Is Related to Treatment Preference in Cancer Patients: Implications for Quality Assessment American Journal of Hospice and Palliative Medicine, February 1, 2007; 24(1): 36 - 41. [Abstract] [PDF]

				K. P. Tercyak, B. N. Peshkin, B. M. Brogan, T. DeMarco, M. F. Pennanen, S. C. Willey, C. M. Magnant, S. Rogers, C. Isaacs, and M. D. Schwartz Quality of Life After Contralateral Prophylactic Mastectomy in Newly Diagnosed High-Risk Breast Cancer Patients Who Underwent BRCA1/2 Gene Testing J. Clin. Oncol., January 20, 2007; 25(3): 285 - 291. [Abstract] [Full Text] [PDF]

				M. E. Ropka, J. Wenzel, E. K. Phillips, M. Siadaty, and J. T. Philbrick Uptake rates for breast cancer genetic testing: a systematic review. Cancer Epidemiol. Biomarkers Prev., May 1, 2006; 15(5): 840 - 855. [Abstract] [Full Text] [PDF]

				C. Hughes, S. K. Peterson, A. Ramirez, K. J. Gallion, P. G. McDonald, C. S. Skinner, and D. Bowen Minority Recruitment in Hereditary Breast Cancer Research Cancer Epidemiol. Biomarkers Prev., July 1, 2004; 13(7): 1146 - 1155. [Abstract] [Full Text] [PDF]

				R Timman, T Stijnen, and A Tibben Methodology in longitudinal studies on psychological effects of predictive DNA testing: a review J. Med. Genet., July 1, 2004; 41(7): e100 - e100. [Abstract] [Full Text] [PDF]

				M. D. Schwartz, C. Lerman, B. Brogan, B. N. Peshkin, C. Hughes Halbert, T. DeMarco, W. Lawrence, D. Main, C. Finch, C. Magnant, et al. Impact of BRCA1/BRCA2 Counseling and Testing on Newly Diagnosed Breast Cancer Patients J. Clin. Oncol., May 15, 2004; 22(10): 1823 - 1829. [Abstract] [Full Text] [PDF]

				C. H. Halbert, L. Wenzel, C. Lerman, B. N. Peshkin, S. Narod, A. Marcus, C. Corio, T. Demarco, and S. Bellamy Predictors of Participation in Psychosocial Telephone Counseling following Genetic Testing for BRCA1 and BRCA2 Mutations Cancer Epidemiol. Biomarkers Prev., May 1, 2004; 13(5): 875 - 881. [Abstract] [Full Text] [PDF]

				M. D. Schwartz, E. Kaufman, B. N. Peshkin, C. Isaacs, C. Hughes, T. DeMarco, C. Finch, and C. Lerman Bilateral Prophylactic Oophorectomy and Ovarian Cancer Screening Following BRCA1/BRCA2 Mutation Testing J. Clin. Oncol., November 1, 2003; 21(21): 4034 - 4041. [Abstract] [Full Text] [PDF]

				B. N. Peshkin, M. D. Schwartz, C. Isaacs, C. Hughes, D. Main, and C. Lerman Utilization of Breast Cancer Screening in a Clinically Based Sample of Women after BRCA1/2 Testing Cancer Epidemiol. Biomarkers Prev., October 1, 2002; 11(10): 1115 - 1118. [Abstract] [Full Text] [PDF]

				M. D. Schwartz, B. N. Peshkin, C. Hughes, D. Main, C. Isaacs, and C. Lerman Impact of BRCA1/BRCA2 Mutation Testing on Psychologic Distress in a Clinic-Based Sample J. Clin. Oncol., January 15, 2002; 20(2): 514 - 520. [Abstract] [Full Text] [PDF]

				A. W. Helmes, D. J. Bowen, R. Bowden, and J. Bengel Predictors of Participation in Genetic Research in a Primary Care Physician Network Cancer Epidemiol. Biomarkers Prev., December 1, 2000; 9(12): 1377 - 1379. [Abstract] [Full Text]